Acute Porphyria Drug Database

C09CA03 - Valsartan
Not porphyrinogenic
NP

Rationale
Not metabolised.
Chemical description
Angiotensin II receptor antagonist. Bioavailability 23 %. Eliminated in unchanged form. Less potent inhibitor of CYP 2C9. Used in Swedish porphyria ward.
IPNet drug reports
Uneventful use reported in 15 patients with acute porphyria.

References

  1. Other sources
  2. EPNET checked 14.04.10. RLSK #1314

Similar drugs
Explore alternative drugs in similar therapeutic classes C09C / C09CA or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙